Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.

American journal of hematology - 1 Jun 2024

Patnaik Mrinal M, Tefferi Ayalew

Abstract excerpt

DISEASE OVERVIEW: Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder with overlapping features of myelodysplastic syndromes and myeloproliferative neoplasms, characterized by prominent monocytosis and an inherent risk for leukemic transformation (~15%-20% over 3-5 years). DIAGNOSIS: Newly revised diagnostic criteria include sustained (>3 months) peripheral blood (PB) monocytosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Leukemia, Myelomonocytic, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 38450850
DOI: 10.1002/ajh.27271
PMCID: PMC11096042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.PMID 38450850Read ↗

Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and managementSemantic proximity Read ↗

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and managementSemantic proximity Read ↗

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and managementSemantic proximity Read ↗

Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

How I diagnose and treat chronic myelomonocytic leukemia.Semantic proximity Read ↗

Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.Semantic proximity Read ↗

Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.Semantic proximity Read ↗

[Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].Semantic proximity Read ↗

Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.Semantic proximity Read ↗

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological reviewSemantic proximity Read ↗

Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.